SCHEMBL10734321

SCHEMBL10734321

COc1cc(N(C)C)ccc1-c1nc2nccnc2[nH]1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE2A O00408 1/20 0.51
PDE5A O76074 4/20 0.44
PDE3B Q13370 2/20 0.44
PDE3A Q14432 2/20 0.44
KDM4E B2RXH2 1/20 0.44
MEN1 O00255 1/20 0.44
ALDH1A1 P00352 1/20 0.44
LMNA P02545 1/20 0.44
CYP1A2 P05177 1/20 0.44
HPGD P15428 1/20 0.44
KMT2A Q03164 1/20 0.44
HSD17B10 Q99714 1/20 0.44
AURKA O14965 6/20 0.43
METAP2 P50579 1/20 0.40
METAP1 P53582 1/20 0.40
TLR9 Q9NR96 1/20 0.38
TLR7 Q9NYK1 1/20 0.38
PDGFRB P09619 1/20 0.38
PDGFRA P16234 1/20 0.38
CCNB2 O95067 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10742148 0.85 PDE2A (0.68) PDE2APDE5APDE3BPDE3AKDM4E
SCHEMBL11767955 0.82 PDE2A (0.76) PDE2APDE5APDE3BPDE3AKDM4E
SCHEMBL10676462 0.82 PDE2A (0.50) PDE2APDE5APDE3BPDE3AKDM4E
SCHEMBL10740380 0.82 PDE2A (0.50) PDE2APDE5APDE3BPDE3AKDM4E
SCHEMBL10733100 0.80 PDE2A (0.48) PDE2APDE5AAURKAMETAP2METAP1
SCHEMBL10673882 0.80 PDE2A (0.48) PDE2APDE5APDE3BPDE3AKDM4E
SCHEMBL10744015 0.80 PDE2A (0.48) PDE2APDE5APDE3BPDE3AKDM4E
SCHEMBL10734555 0.79 PDE2A (0.56) PDE2APDE5APDE3BPDE3AKDM4E
SCHEMBL10735438 0.79 PDE2A (0.47) PDE2APDE5APDE3BPDE3AKDM4E
SCHEMBL10737707 0.78 PDE5A (0.68) PDE2APDE5AALDH1A1AURKAMETAP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4654344-A ALSO AFFECT BLOOD PRESSURE AND MYOCARDIAL CONTRACTIONS MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1987-03-31 US disclosed
EP-0093951-B1 2-ARYL-TETRAAZAINDENES MERCK PATENT GmbH (DE) 1986-10-29 EP disclosed
US-4575505-A Pharmaceutical compositions containing 2-aryltetraazaindenes for treating ulcers or cardiac insufficiency or blood pressure abnormalities MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1986-03-11 US disclosed
US-4477454-A INDOTROPIC AGENTS MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1984-10-16 US disclosed
EP-0093951-A2 2-Aryl-tetraazaindenes MERCK PATENT GmbH (DE) 1983-11-16 EP disclosed